TREANDA - 63459-391-20 - (bendamustine hydrochloride)

Alphabetical Index


Drug Information of TREANDA

Product NDC: 63459-391
Proprietary Name: TREANDA
Non Proprietary Name: bendamustine hydrochloride
Active Ingredient(s): 100    mg/20mL & nbsp;   bendamustine hydrochloride
Administration Route(s): INTRAVENOUS
Dosage Form(s): INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of TREANDA

Product NDC: 63459-391
Labeler Name: Cephalon, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA022249
Marketing Category: NDA
Start Marketing Date: 20080320

Package Information of TREANDA

Package NDC: 63459-391-20
Package Description: 20 mL in 1 VIAL, SINGLE-USE (63459-391-20)

NDC Information of TREANDA

NDC Code 63459-391-20
Proprietary Name TREANDA
Package Description 20 mL in 1 VIAL, SINGLE-USE (63459-391-20)
Product NDC 63459-391
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name bendamustine hydrochloride
Dosage Form Name INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route Name INTRAVENOUS
Start Marketing Date 20080320
Marketing Category Name NDA
Labeler Name Cephalon, Inc.
Substance Name BENDAMUSTINE HYDROCHLORIDE
Strength Number 100
Strength Unit mg/20mL
Pharmaceutical Classes Alkylating Activity [MoA],Alkylating Drug [EPC]

Complete Information of TREANDA


General Information